Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Butler

Showing results (151-160 of 160) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 160 results.
Pharmaceutics|May 4, 2026
TIM-1 and Tiny-TIM as Robust In Vitro Models for Oral Biopharmaceutics: Evidence from an International Ring StudyConnor O'Farrell, Robert Havenaar, Mark McAllister, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's DiseaseJustin Tao Wen Chiam, Katie Lunnon, Nicola Voyle, et al.
Journal of Pharmaceutical Sciences|October 15, 2020
Best Practices in the Development and Validation of Physiologically Based Biopharmaceutics Modeling. A Workshop Summary ReportNeil Parrott, Sandra Suarez-Sharp, Filippos Kesisoglou, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|January 9, 2025
Intertwined people-nature relations are central to nature-based adaptation to climate changeBruno Locatelli, Sandra Lavorel, Matthew J Colloff, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 24, 2018
In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaborationJames Butler, Bart Hens, Maria Vertzoni, et al.
Pharmaceutics|May 27, 2026
Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary ReportMark McAllister, Nena Mistry, Xavier Pepin, et al.
The Lancet. Oncology|June 14, 2021
Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trialArjun Sahgal, Sten D Myrehaug, Shankar Siva, et al.
Advanced Drug Delivery Reviews|February 21, 2021
Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP networkZahari Vinarov, Bertil Abrahamsson, Per Artursson, et al.
Epilepsia|June 2, 2026
Pediatric epilepsy surgery: Global survey of referral and presurgical evaluation practicesGeorgia Ramantani, J Helen Cross, Dorottya Cserpan, et al.
Brain : a Journal of Neurology|November 23, 2022
Predictive models for starting antiseizure medication withdrawal following epilepsy surgery in adultsCarolina Ferreira-Atuesta, Jane de Tisi, Andrew W McEvoy, et al.
Pageof 16

Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Pharmaceutics|May 4, 2026
TIM-1 and Tiny-TIM as Robust In Vitro Models for Oral Biopharmaceutics: Evidence from an International Ring StudyConnor O'Farrell, Robert Havenaar, Mark McAllister, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's DiseaseJustin Tao Wen Chiam, Katie Lunnon, Nicola Voyle, et al.
Journal of Pharmaceutical Sciences|October 15, 2020
Best Practices in the Development and Validation of Physiologically Based Biopharmaceutics Modeling. A Workshop Summary ReportNeil Parrott, Sandra Suarez-Sharp, Filippos Kesisoglou, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|January 9, 2025
Intertwined people-nature relations are central to nature-based adaptation to climate changeBruno Locatelli, Sandra Lavorel, Matthew J Colloff, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 24, 2018
In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaborationJames Butler, Bart Hens, Maria Vertzoni, et al.
Pharmaceutics|May 27, 2026
Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary ReportMark McAllister, Nena Mistry, Xavier Pepin, et al.
The Lancet. Oncology|June 14, 2021
Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trialArjun Sahgal, Sten D Myrehaug, Shankar Siva, et al.
Advanced Drug Delivery Reviews|February 21, 2021
Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP networkZahari Vinarov, Bertil Abrahamsson, Per Artursson, et al.
Epilepsia|June 2, 2026
Pediatric epilepsy surgery: Global survey of referral and presurgical evaluation practicesGeorgia Ramantani, J Helen Cross, Dorottya Cserpan, et al.
Brain : a Journal of Neurology|November 23, 2022
Predictive models for starting antiseizure medication withdrawal following epilepsy surgery in adultsCarolina Ferreira-Atuesta, Jane de Tisi, Andrew W McEvoy, et al.
Pageof 16